182.40CHF-0.65%Mkt Cap: 2.63B $P/E: —1d ago
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Busi…
Industry Peers
Medical Instruments & SuppliesIndicators:|
Key Statistics
Company
Market Cap2.63B $
Enterprise Value2.50B $
Revenue (TTM)1.01B $
Gross Profit354.76M $
Net Income (TTM)-126.29M $
Revenue/Share79.54 USD
Last Price182.40 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees3.0K
CountryCH
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)23.69
PEG1.71
EV/EBITDA27.12
EV/Revenue2.49
P/S2.62
P/B1.99
EPS (TTM)-8.74
EPS (Forward)7.70
52W Range
110.6095% of range186.40
52W High186.40 CHF
52W Low110.60 CHF
Profitability
Gross Margin35.22%
Oper. Margin4.93%
EBITDA Margin9.16%
Profit Margin-12.54%
ROE-9.61%
ROA-6.52%
Growth
Revenue Growth-5.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF157.47M $
CapEx (TTM)40.29M $
FCF Margin12.86%
FCF Yield4.92%
Net Debt-106.19M $
Net Debt/EBITDA-1.15
Balance Sheet
Debt/Equity0.19
Current Ratio2.46
Quick Ratio1.69
Book Value/Sh91.87 CHF
Cash/Share24.84 CHF
Dividends
Fwd Div Rate3.000 CHF
Trail. Div Rate3.000 CHF
Div. Yield1.63%
5Y Avg Yield1.16%
Payout Ratio60.61%
Ex-Div DateApr 17, 2026
Pay DateApr 16, 2025
Analyst Consensus
Rating2.1 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)175.47 CHF
Upside (mean)-3.8%
Target Range142.00 CHF – 220.00 CHF
CHF142.00-3.8% to meanCHF220.00
# Analysts8
Ownership
Shares Out.12.66M
Float12.48M
Insiders0.43%
Institutions63.98%
Technical
SMA 50155.22 (+17.5%)
SMA 200140.32 (+30.0%)
Beta1.07
S&P 52W Chg19.63%
Avg Vol (30d)49.16K
Avg Vol (10d)45.54K
Technical Indicators
RSI (14)66.7
MACD8.5355
MACD Signal7.7547
MACD Hist.+0.7808
BB Upper194.74 CHF
BB Middle169.38 CHF
BB Lower144.03 CHF
BB Width29.94%
ATR (14)5.841 CHF
Vol Ratio (20d)0.97x